.

Deeper Knowledge, Faster

  • Obtain formulation and manufacturing information
  • Drug patents and clinical trials in dozens of countries
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Farmers Insurance
Teva
Cantor Fitzgerald
Federal Trade Commission
Citi
McKesson
Cerilliant
US Army
Fish and Richardson

Generated: June 24, 2017

DrugPatentWatch Database Preview

Pentetate calcium trisodium - Generic Drug Details

« Back to Dashboard

What are the generic sources for pentetate calcium trisodium and what is the scope of pentetate calcium trisodium patent protection?

Pentetate calcium trisodium
is the generic ingredient in two branded drugs marketed by Hameln Pharma Plus and 3M, and is included in two NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for pentetate calcium trisodium. One supplier is listed for this compound.

Summary for Generic Name: pentetate calcium trisodium

Tradenames:2
Patents:1
Applicants:2
NDAs:2
Drug Master File Entries: see list1
Suppliers / Packagers: see list1
Clinical Trials: see list1,760
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:pentetate calcium trisodium at DailyMed

Pharmacology for Ingredient: pentetate calcium trisodium

Drug ClassLead Chelator
Mechanism of ActionLead Chelating Activity
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
3m
YTTERBIUM YB 169 DTPA
pentetate calcium trisodium yb-169
INJECTABLE;INJECTION017518-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Hameln Pharma Plus
PENTETATE CALCIUM TRISODIUM
pentetate calcium trisodium
SOLUTION;INHALATION, INTRAVENOUS021749-001Aug 11, 2004RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Novartis
QuintilesIMS
Mallinckrodt
Express Scripts
Deloitte
Moodys
Covington
Argus Health
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot